DaebongLS Co

DaebongLS Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of DaebongLS Co (078140.KQ) as of Oct 28, 2026 is 2.77 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 3.79 % — a change of -27.05% (lower).

EBIT/Assets

2.77 %

YoY

-27.05%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of DaebongLS Co is 2025 2.77 % . Operating Income to Assets Ratio (EBIT/Assets) of DaebongLS Co was 2024 3.79 % . It decreases by -27.05% lower compared to the previous year.

The DaebongLS Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
9.11 KRW
Jan 1, 2019
7.03 KRW
Jan 1, 2020
5.42 KRW
Jan 1, 2021
5.93 KRW
Jan 1, 2022
4.39 KRW
Jan 1, 2023
1.95 KRW
Jan 1, 2024
3.79 KRW
Jan 1, 2025
2.77 KRW
The DaebongLS Co EBIT/Assets history
YEAREBIT/AssetsYoY
2.77 %-27.05%
3.79 %+94.51%
1.95 %-55.60%
4.39 %-25.99%
5.93 %+9.43%
5.42 %-22.89%
7.03 %-22.84%
9.11 %-19.78%
11.36 %-23.45%
14.84 %+14.33%
12.98 %+15.56%
11.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DaebongLS Co Stock analysis

What does DaebongLS Co do? DaebongLS Co., Ltd. generates revenue through the manufacturing and distribution of raw materials for pharmaceuticals and cosmetics, operating via two primary divisions. The cosmetic division supplies aloe vera gels, beta carotens, calamines, diaformers, emulgades, emulsifiers, emollients, polymers, and thickeners for various beauty and skincare products. The pharmaceutical division provides almagates, bentonites, calcitriols, erdosteines, and fish oil for antibiotics, cough products, and expectorants. The company serves domestic markets in Korea and exports to Japan, America, and Southeast Asian countries, focusing on clients in the pharmaceutical, cosmetic, and food chemical industries. DaebongLS Co., Ltd. also offers food chemical additives and fish feedstuff as part of its product portfolio, catering to additional market segments. Its customers include manufacturers requiring raw materials for pharmaceutical formulations, cosmetic product development, and food additive production. The company leverages its domestic presence in Incheon and international distribution channels to reach clients in Japan, America, and Southeast Asia, ensuring steady demand for its specialized chemical inputs. The firm’s revenue streams are derived from the sale of these specialized raw materials across multiple sectors, with a strong emphasis on pharmaceutical and cosmetic applications. Its product range supports both direct consumer goods and industrial manufacturing needs, allowing it to maintain a diversified client base. By distributing within Korea and internationally, DaebongLS Co., Ltd. ensures consistent market access for its offerings. DaebongLS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DaebongLS Co stock

Operating Income to Assets Ratio (EBIT/Assets) of DaebongLS Co is 2.77 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of DaebongLS Co changed from 3.79 % to 2.77 %, representing a -27.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) DaebongLS Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s DaebongLS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — DaebongLS Co

All Key Metrics — DaebongLS Co